SCHEMBL4748615

SCHEMBL4748615

COc1cccc(C(=O)Cc2ccc(C#N)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.56
CBX7 O95931 1/20 0.53
CDYL2 Q8N8U2 1/20 0.53
CDY1; CDY1B Q9Y6F8 1/20 0.53
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
SMPD1 P17405 1/20 0.51
P4HB P07237 1/20 0.50
NPC1 O15118 1/20 0.50
POLB P06746 1/20 0.50
BLM P54132 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KMT2A Q03164 2/20 0.49
PARP1 P09874 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.48
HSD11B1 P28845 2/20 0.48
CHRM2 P08172 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27572327 0.87 ALDH1A1 (0.63) RAB9ACES2CES1SMPD1NPC1
SCHEMBL6207604 0.84 RAB9A (0.59) RAB9ANPC1POLBSMN1; SMN2ALDH1A1
SCHEMBL6210030 0.84 RAB9A (0.59) RAB9ANPC1POLBSMN1; SMN2ALDH1A1
SCHEMBL1515775 0.84 MEN1 (0.61) RAB9ACES2CES1NPC1SMN1; SMN2
SCHEMBL2477853 0.80 LMNA (0.54) RAB9ACES2CES1NPC1SMN1; SMN2
SCHEMBL2768472 0.80 CYP11B1 (0.48) RAB9ASMPD1NPC1MAPTKMT2A
SCHEMBL18326345 0.79 MEN1 (0.62) RAB9ACES2CES1NPC1POLB
SCHEMBL25196861 0.79 SMPD1 (0.62) RAB9ASMPD1
SCHEMBL30391457 0.79 SMPD1 (0.62) RAB9ASMPD1
SCHEMBL1515736 0.79 CTBP2 (0.54) RAB9ANPC1POLBSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed